LYSIS SOLUTION - ANVISA Registration 10287411704

Access comprehensive regulatory information for LYSIS SOLUTION in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 10287411704 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIAGNO SOLUÇÕES EM DIAGNÓSTICO LTDA, SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287411704
Registration Details
ANVISA Registration Number: 10287411704
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Glucose Hemolyzing Reagent
Risk Class I

Registration Details

10287411704

25351393000202479

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Oct 07, 2024

VIGENTE

09/18/2025 19:00:01